Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospective, Community-Dwelling Cohort Study

다국어 초록 (Multilingual Abstract)

Background: While the triglyceride-glucose (TyG) index is a measure of insulin resistance, its association with cardiovascular disease (CVD) has not been well elucidated. We evaluated the TyG index for prediction of CVDs in a prospective large communitybased cohort.
Methods: Individuals 40 to 70 years old were prospectively followed for a median 15.6 years. The TyG index was calculated as the Ln [fasting triglycerides (mg/dL)×fasting glucose (mg/dL)/2]. CVDs included any acute myocardial infarction, coronary artery disease or cerebrovascular disease. We used a Cox proportional hazards model to estimate CVD risks according to quartiles of the TyG index and plotted the receiver operating characteristics curve for the incident CVD.
Results: Among 8,511 subjects (age 51.9±8.8 years; 47.5% males), 931 (10.9%) had incident CVDs during the follow-up. After adjustment for age, sex, body mass index, diabetes mellitus, hypertension, total cholesterol, smoking, alcohol, exercise, and C-reactive protein, subjects in the highest TyG quartile had 36% increased risk of incident CVD compared with the lowest TyG quartile (hazard ratio, 1.36; 95% confidence interval, 1.10 to 1.68). Carotid plaque, assessed by ultrasonography was more frequent in subjects in the higher quartile of TyG index (P for trend=0.049 in men and P for trend <0.001 in women). The TyG index had a higher predictive power for CVDs than the homeostasis model assessment of insulin resistance (HOMA-IR) (area under the curve, 0.578 for TyG and 0.543 for HOMA-IR). Adding TyG index on diabetes or hypertension alone gave sounder predictability for CVDs.
Conclusion: The TyG index is independently associated with future CVDs in 16 years of follow-up in large, prospective Korean cohort.

참고문헌 (Reference)

• 1 배재현 ; 문민경 ; 오소희 ; 구보경 ; 조남한 ; 이문규, "Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort" 대한당뇨병학회 44 (44): 458-469, 2020
• 2 Sarwar N, "Triglycerides and the risk of coronary heart disease : 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies" 115 : 450-458, 2007
• 3 Nordestgaard BG, "Triglycerides and cardiovascular disease" 384 : 626-635, 2014
• 4 Duran EK, "Triglyceride-rich lipoprotein cholesterol, small dense ldl cholesterol, and incident cardiovascular disease" 75 : 2122-2135, 2020
• 5 Navarro-Gonzalez D, "Triglyceride-glucose index(TyG index)in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose : the Vascular-Metabolic CUN cohort" 86 : 99-105, 2016
• 6 da Silva A, "Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care" 18 : 89-, 2019
• 7 조윤경 ; Han Kyungdo ; Kim Hwi Seung ; 정창희 ; 박중열 ; 이우제, "Triglyceride-Glucose Index Is a Useful Marker for Predicting Future Cardiovascular Disease and Mortality in Young Korean Adults: A Nationwide Population-Based Cohort Study" 한국지질동맥경화학회 11 (11): 178-186, 2022
• 8 Park B, "The triglyceride-glucose index predicts ischemic heart disease risk in Koreans : a prospective study using National Health Insurance Service data" 19 : 210-, 2020
• 9 Hong S, "The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease : a population-based study" 18 : 361-, 2020
• 10 Guerrero-Romero F, "The product of triglycerides and glucose, a simple measure of insulin sensitivity : comparison with the euglycemic-hyperinsulinemic clamp" 95 : 3347-3351, 2010
• 11 Simental-Mendia LE, "The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects" 6 : 299-304, 2008
• 12 Sanchez-Inigo L, "The TyG index may predict the development of cardiovascular events" 46 : 189-197, 2016
• 13 Elam M, "The ACCORD-Lipid study : implications for treatment of dyslipidemia in type 2 diabetes mellitus" 6 : 9-20, 2011
• 14 Jung KJ, "The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease" 242 : 367-375, 2015
• 15 Mosca L, "Sex/gender differences in cardiovascular disease prevention : what a difference a decade makes" 124 : 2145-2154, 2011
• 16 Barrett-Connor E, "Sex differences in coronary heart disease:why are women so superior? The 1995 Ancel Keys Lecture" 95 : 252-264, 1997
• 17 Kim MK, "Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults" 16 : 108-, 2017
• 18 Jeppesen J, "Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease : an 8-year follow-up in the Copenhagen Male Study" 17 : 1114-1120, 1997
• 19 Wilson PW, "Prediction of coronary heart disease using risk factor categories" 97 : 1837-1847, 1998
• 20 AIM-HIGH Investigators, "Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy" 365 : 2255-2267, 2011
• 21 Wilson PW, "Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus" 112 : 3066-3072, 2005
• 22 Indrayan A, "Medical biostatistics" CRC Press 962-, 2013
• 23 Michos ED, "Lipid management for the prevention of atherosclerotic cardiovascular disease" 381 : 1557-1567, 2019
• 24 Kang ES, "Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea" 54 : 206-211, 2005
• 25 Levitan EB, "Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? : a metaanalysis of prospective studies" 164 : 2147-2155, 2004
• 26 Semenkovich CF, "Insulin resistance and atherosclerosis" 116 : 1813-1822, 2006
• 27 Austin MA, "Hypertriglyceridemia as a cardiovascular risk factor" 81 (81): 7-, 1998
• 28 Matthews DR, "Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man" 28 : 412-419, 1985
• 29 Choi SH, "Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction : a 6-year community-based prospective study" 34 : 944-949, 2011
• 30 Bonora E, "HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects : prospective data from the Verona Diabetes Complications Study" 25 : 1135-1141, 2002
• 31 Juutilainen A, "Gender difference in the impact of type 2 diabetes on coronary heart disease risk" 27 : 2898-2904, 2004
• 32 Sabatine MS, "Evolocumab and clinical outcomes in patients with cardiovascular disease" 376 : 1713-1722, 2017
• 33 Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge" 18 : 499-502, 1972
• 34 Hu FB, "Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes" 25 : 1129-1134, 2002
• 35 ACCORD Study Group, "Effects of combination lipid therapy in type 2 diabetes mellitus" 362 : 1563-1574, 2010
• 36 Grundy SM, "Diagnosis and management of the metabolic syndrome : an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement" 112 : 2735-2752, 2005
• 37 American Diabetes Association, "Diagnosis and classification of diabetes mellitus" 27 (27): S5-S10, 2004
• 38 Kim Y, "Cohort profile : the Korean Genome and Epidemiology Study(KoGES)consortium" 46 : e20-, 2017
• 39 Garcia M, "Cardiovascular disease in women : clinical perspectives" 118 : 1273-1293, 2016
• 40 Lee SB, "Association between triglyceride glucose index and arterial stiffness in Korean adults" 17 : 41-, 2018
• 41 Cho NH, "Abnormal liver function test predicts type 2 diabetes : a community-based prospective study" 30 : 2566-2568, 2007
• 42 이은정 ; 김현창 ; 김재현 ; 이은영 ; 김병진 ; 김은미 ; 송윤주 ; 임정현 ; 김해진 ; 최성훈 ; 문민경 ; 나진오 ; 박광열 ; 오미선 ; 한상엽 ; 노정현 ; 이경희 ; 이상학 ; 홍순철 ; 정인경, "2018 Guidelines for the management of dyslipidemia" 대한내과학회 34 (34): 723-771, 2019
• 43 Goff DC Jr, "2013 ACC/AHA guideline on the assessment of cardiovascular risk : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines" 129 (129): S49-S73, 2014
• 44 Ohn JH, "10-Year trajectory of b-cell function and insulin sensitivity in the development of type 2 diabetes : a community-based prospective cohort study" 4 : 27-34, 2016